ASLAN Pharmaceuticals Limited
ASLAN Pharmaceuticals Limited (ASLN) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001722926 · ASLN · NASDAQ · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001722926 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
No recent filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) has submitted 217 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2018. As a Healthcare sector company with CIK 0001722926, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is ASLAN Pharmaceuticals Limited's most comprehensive regulatory disclosure. The most recent ASLAN Pharmaceuticals Limited 10-K was filed on 2024-04-12 for fiscal year ending 2024. Historical ASLN 10-K annual reports are available from 2017 through 2024.
Investors researching ASLAN Pharmaceuticals Limited SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
ASLN SEC Filings · 8 questionsASLAN Pharmaceuticals Limited (ASLN) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 217 filings and access original documents at no cost. ASLAN Pharmaceuticals Limited's CIK is 0001722926.